HighTide Therapeutics Management
Management criteria checks 1/4
HighTide Therapeutics' CEO is Liping Liu, appointed in Feb 2018, has a tenure of 6.25 years. total yearly compensation is CN¥14.66M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 0.96% of the company’s shares, worth HK$34.20M. The average tenure of the management team and the board of directors is 2.3 years and 1.3 years respectively.
Key information
Liping Liu
Chief executive officer
CN¥14.7m
Total compensation
| CEO salary percentage | 24.1% |
| CEO tenure | 6.3yrs |
| CEO ownership | 1.0% |
| Management average tenure | 2.3yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥15m | CN¥4m | -CN¥939m |
| Sep 30 2023 | n/a | n/a | -CN¥803m |
| Jun 30 2023 | n/a | n/a | -CN¥666m |
| Mar 31 2023 | n/a | n/a | -CN¥428m |
| Dec 31 2022 | CN¥7m | CN¥4m | -CN¥190m |
| Dec 31 2021 | CN¥7m | CN¥3m | -CN¥221m |
Compensation vs Market: Liping's total compensation ($USD2.03M) is above average for companies of similar size in the Hong Kong market ($USD405.74K).
Compensation vs Earnings: Liping's compensation has increased whilst the company is unprofitable.
CEO
Liping Liu (53 yo)
6.3yrs
Tenure
CN¥14,663,000
Compensation
Dr. Liping Liu has been the Chief Executive Officer and Executive Director of HighTide Therapeutics, Inc. since February 28, 2018 and its chairwoman since December 22, 2023 She has been the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairwoman | 6.3yrs | CN¥14.66m | 0.96% CN¥ 34.2m | |
| Deputy GM & Executive Director | 6.9yrs | CN¥10.83m | 0.34% CN¥ 12.1m | |
| Chief Financial Officer | 1.4yrs | no data | no data | |
| Chief Development Officer | 3.3yrs | no data | no data | |
| VP & Joint Company Secretary | less than a year | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data |
2.3yrs
Average Tenure
49.5yo
Average Age
Experienced Management: 2511's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairwoman | 6.3yrs | CN¥14.66m | 0.96% CN¥ 34.2m | |
| Deputy GM & Executive Director | less than a year | CN¥10.83m | 0.34% CN¥ 12.1m | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 3.5yrs | CN¥1.84m | 0.17% CN¥ 5.9m | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.5yrs | no data | no data | |
| Non-Executive Director | 2.5yrs | CN¥8.90m | 0.19% CN¥ 6.8m | |
| Independent Non-Executive Director | less than a year | CN¥4.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
1.3yrs
Average Tenure
51.5yo
Average Age
Experienced Board: 2511's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.